These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

432 related items for PubMed ID: 27147334

  • 1. MRI-alone radiation therapy planning for prostate cancer: Automatic fiducial marker detection.
    Ghose S, Mitra J, Rivest-Hénault D, Fazlollahi A, Stanwell P, Pichler P, Sun J, Fripp J, Greer PB, Dowling JA.
    Med Phys; 2016 May; 43(5):2218. PubMed ID: 27147334
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A generative adversarial network-based (GAN-based) architecture for automatic fiducial marker detection in prostate MRI-only radiotherapy simulation images.
    Singhrao K, Fu J, Parikh NR, Mikaeilian AG, Ruan D, Kishan AU, Lewis JH.
    Med Phys; 2020 Dec; 47(12):6405-6413. PubMed ID: 32989773
    [Abstract] [Full Text] [Related]

  • 4. Registration free automatic identification of gold fiducial markers in MRI target delineation images for prostate radiotherapy.
    Gustafsson C, Korhonen J, Persson E, Gunnlaugsson A, Nyholm T, Olsson LE.
    Med Phys; 2017 Nov; 44(11):5563-5574. PubMed ID: 28803447
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Characterization of a novel liquid fiducial marker for multimodal image guidance in stereotactic body radiotherapy of prostate cancer.
    De Roover R, Crijns W, Poels K, Peeters R, Draulans C, Haustermans K, Depuydt T.
    Med Phys; 2018 May; 45(5):2205-2217. PubMed ID: 29537613
    [Abstract] [Full Text] [Related]

  • 10. Internal fiducial markers and susceptibility effects in MRI-simulation and measurement of spatial accuracy.
    Jonsson JH, Garpebring A, Karlsson MG, Nyholm T.
    Int J Radiat Oncol Biol Phys; 2012 Apr 01; 82(5):1612-8. PubMed ID: 21477942
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Development and evaluation of a deep learning based artificial intelligence for automatic identification of gold fiducial markers in an MRI-only prostate radiotherapy workflow.
    Gustafsson CJ, Swärd J, Adalbjörnsson SI, Jakobsson A, Olsson LE.
    Phys Med Biol; 2020 Nov 12; 65(22):225011. PubMed ID: 33179610
    [Abstract] [Full Text] [Related]

  • 13. Regression and statistical shape model based substitute CT generation for MRI alone external beam radiation therapy from standard clinical MRI sequences.
    Ghose S, Greer PB, Sun J, Pichler P, Rivest-Henault D, Mitra J, Richardson H, Wratten C, Martin J, Arm J, Best L, Dowling JA.
    Phys Med Biol; 2017 Oct 27; 62(22):8566-8580. PubMed ID: 28976369
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Quantification of fiducial marker visibility for MRI-only prostate radiotherapy simulation.
    Singhrao K, Ruan D, Fu J, Gao Y, Chee G, Yang Y, King C, Hu P, Kishan AU, Lewis JH.
    Phys Med Biol; 2020 Feb 05; 65(3):035015. PubMed ID: 31881546
    [Abstract] [Full Text] [Related]

  • 16. MR-PROTECT: Clinical feasibility of a prostate MRI-only radiotherapy treatment workflow and investigation of acceptance criteria.
    Persson E, Jamtheim Gustafsson C, Ambolt P, Engelholm S, Ceberg S, Bäck S, Olsson LE, Gunnlaugsson A.
    Radiat Oncol; 2020 Apr 09; 15(1):77. PubMed ID: 32272943
    [Abstract] [Full Text] [Related]

  • 17. Utilizing the TrueBeam Advanced Imaging Package to monitor intrafraction motion with periodic kV imaging and automatic marker detection during VMAT prostate treatments.
    Korpics MC, Rokni M, Degnan M, Aydogan B, Liauw SL, Redler G.
    J Appl Clin Med Phys; 2020 Mar 09; 21(3):184-191. PubMed ID: 31981305
    [Abstract] [Full Text] [Related]

  • 18. IMRT boost dose planning on dominant intraprostatic lesions: gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI.
    van Lin EN, Fütterer JJ, Heijmink SW, van der Vight LP, Hoffmann AL, van Kollenburg P, Huisman HJ, Scheenen TW, Witjes JA, Leer JW, Barentsz JO, Visser AG.
    Int J Radiat Oncol Biol Phys; 2006 May 01; 65(1):291-303. PubMed ID: 16618584
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. An atlas-based electron density mapping method for magnetic resonance imaging (MRI)-alone treatment planning and adaptive MRI-based prostate radiation therapy.
    Dowling JA, Lambert J, Parker J, Salvado O, Fripp J, Capp A, Wratten C, Denham JW, Greer PB.
    Int J Radiat Oncol Biol Phys; 2012 May 01; 83(1):e5-11. PubMed ID: 22330995
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.